Back

Dapagliflozin suppresses vascular smooth muscle cell senescence by promoting autophagy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hui Yang

The Second Xiangya Hospital of Central South University, Changsha (China)

7 More presentations in this session

Presentation thumbnail
PI3Ka protects against arteriosclerosis progression and plaque instability by controlling vascular smooth muscle cell functions
Doctor M. Zierden (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
VasCraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass
Mrs G. Iraola Picornell (Badalona, Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Evidence from normal human arteries: IRF7 triggers atherosclerosis by enhancing vascular smooth muscle cells inflammation
Doctor S. Cheng (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Mass spectrometry-based proteomics identifies high glucose-induced changes in vascular smooth muscle (VSMCs) and sustained extracellular signal-regulated kinases (ERK) activation
Mrs R. Aldahhasi (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
MicroRNA-31-5p promotes vascular remodeling by modulating smooth muscle cell activity via STK40
Doctor K. Kalies (Halle, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Molecular mechanisms of cardiovascular ageing: from senescence to regeneration
thumbnail
Congress Session
Vascular ageing: from mechanisms to therapeutic targets
thumbnail
Congress Session
Mechanisms of ageing in cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources